The antibody's effectiveness was tested in clinical trials where it showed it can prevent reoccurence of c.difficile in 10 to 15 percent of the cases.
12 Aug '24 10:39AM
09 Aug '24 16:35PM
09 Aug '24 16:25PM
09 Aug '24 15:37PM